|
|
|
|
Science Sparks @ ACTREC
|
 27th July 2026 |
Vol. No. 15 ; Issue No.745 |
|
|
Publications
|
|
1. Chakraborty S, Shenoy PS, Nath S, Panda TR, Bhat A, Sakpal A, Mehrotra M, Singh P, Patra M, Ray P (2026). A kinetically inert platinum antitumor agent overcomes mutant p53-driven chemoresistance via oxidative stress-mediated DNA damage. Medical Oncology.;43(9):232.
2. Choudhari D, Chatterjee A, Gulia A, Salunkhe B (2026). Postoperative Pain Severity, Incidence of Chronic Pain, and Impact on Daily Function following Oncological Total Knee Replacements at Tertiary care centre. Indian Journal of Orthopaedics. 18;60(7):1684-1694.
3. Pruthi M, Reddy A, Gulia A, Nayak P, Panjwani P, Puri A (2026). Evaluation of the Prognostic and Therapeutic Factors Affecting Outcomes in Parosteal Osteosarcoma of Bone. Indian Journal of Orthopaedics.;60(7):1641-1653.
4. Priya RL, Poriwade S, Parthasarathy A, Movva SH, Shinde I, Redhu AK, Chandrani P, Gota V (2026). FloraMediX: AI-enabled recognition and therapeutic profiling analysis of indian medicinal flora. Frontiers in Bioinformatics. 6:1864201.
5. Singh S, Wang Y, Sircar A, Jindal U, Srour N, La Ferlita A, Distefano R, Soni A, Kumar D, Peralta-Camacho GJ, Zhao SL, Jafari H, Holter JC, Tinapple JW, Barlage JM, Kumar R, Berger M, Rahman K, Nezati R, Nath UK, Chaudhary N, Ranganathan P, Muthusamy N, Amador V, Li PK, Parekh S, Paik J, Baiocchi R, Song JW, Alinari L, Peterson BR, Epperla N, Jain N, Sehgal L (2026). Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models. Biomarker Research. 14(1):84.
6. Gupta T, Dasgupta A, Chatterjee A, Chinnaswamy G (2026). Comment on: Group 4 Medulloblastomas of early childhood treated with high-dose chemotherapy- and craniospinal irradiation-Sparing approach-finding the right balance between survival and Survivorship. Pediatric Blood Cancer.
7.
Agrawal R, Parghane RV, Joshi A, Prabhash K, Basu S (2026). Evaluation of [225Ac]Ac-PSMA-617 vis-a-vis Rechallenge [177Lu]Lu-PSMA-617 PRLT Versus cabazitaxel or oral metronomic chemotherapy in mCRPC: An observational analysis of outcome and toxicity profiles in a real-world clinical scenario. Prostate.
|
|
|
|
|
|
|
Video of the Week
|
.jpg)
|
| From Screening to Precision Prevention: AI in Breast Cancer Detection and Care (ESIL) |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2012, Smart-seq, a method to generate high-coverage transcriptomes from single cells, was used to analyse the full-length messenger-RNA transcriptomes of circulating tumour cells from a patient with melanoma.
|
|
|
|
Cancer News
|
| |
|
New cancer strategy could stop tumors before resistance takes hold.
|
|
Sciencedaily, 22/07/2026
|
|
Researchers are applying evolutionary theory to cancer by changing treatments before tumors have time to develop resistance. Mathematical models suggest that rapid, carefully timed switches between multiple therapies could improve cure rates...
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
